Novo CEO pressed by Senate to cut rates of weight problems, diabetes medicine CEO Lars Fruergaard Jørgensen advised lawmakers the company would take into consideration new talks with insurers in regards to the record charges of Wegovy and copyright whenever they pledge to keep the medicines on their formularies. Will https://daveshotchickennutrition61616.blogdigy.com/everything-about-healthcare-news-45760790